3ej8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:47, 21 February 2024) (edit) (undo)
 
Line 3: Line 3:
<StructureSection load='3ej8' size='340' side='right'caption='[[3ej8]], [[Resolution|resolution]] 2.55&Aring;' scene=''>
<StructureSection load='3ej8' size='340' side='right'caption='[[3ej8]], [[Resolution|resolution]] 2.55&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[3ej8]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EJ8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3EJ8 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[3ej8]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EJ8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3EJ8 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=H4B:5,6,7,8-TETRAHYDROBIOPTERIN'>H4B</scene>, <scene name='pdbligand=HEC:HEME+C'>HEC</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.55&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[3e65|3e65]], [[3e67|3e67]], [[3e68|3e68]], [[3e6l|3e6l]], [[3e6n|3e6n]], [[3e6o|3e6o]], [[3e6t|3e6t]], [[3e7g|3e7g]], [[3e7i|3e7i]], [[3e7m|3e7m]], [[3e7s|3e7s]], [[3e7t|3e7t]], [[3eah|3eah]], [[3eai|3eai]], [[3ebd|3ebd]], [[3ebf|3ebf]]</div></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=H4B:5,6,7,8-TETRAHYDROBIOPTERIN'>H4B</scene>, <scene name='pdbligand=HEC:HEME+C'>HEC</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Nos2A, NOS2 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+
-
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/Nitric-oxide_synthase_(NADPH_dependent) Nitric-oxide synthase (NADPH dependent)], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] </span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ej8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ej8 OCA], [https://pdbe.org/3ej8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ej8 RCSB], [https://www.ebi.ac.uk/pdbsum/3ej8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ej8 ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ej8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ej8 OCA], [https://pdbe.org/3ej8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ej8 RCSB], [https://www.ebi.ac.uk/pdbsum/3ej8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ej8 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[https://www.uniprot.org/uniprot/NOS2_HUMAN NOS2_HUMAN]] Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2.
+
[https://www.uniprot.org/uniprot/NOS2_HUMAN NOS2_HUMAN] Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2.
== Evolutionary Conservation ==
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
[[Image:Consurf_key_small.gif|200px|right]]
Line 22: Line 20:
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3ej8 ConSurf].
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3ej8 ConSurf].
<div style="clear:both"></div>
<div style="clear:both"></div>
-
<div style="background-color:#fffaf0;">
 
-
== Publication Abstract from PubMed ==
 
-
Nitric oxide synthase (NOS) enzymes synthesize nitric oxide, a signal for vasodilatation and neurotransmission at low concentrations and a defensive cytotoxin at higher concentrations. The high active site conservation among all three NOS isozymes hinders the design of selective NOS inhibitors to treat inflammation, arthritis, stroke, septic shock and cancer. Our crystal structures and mutagenesis results identified an isozyme-specific induced-fit binding mode linking a cascade of conformational changes to a new specificity pocket. Plasticity of an isozyme-specific triad of distant second- and third-shell residues modulates conformational changes of invariant first-shell residues to determine inhibitor selectivity. To design potent and selective NOS inhibitors, we developed the anchored plasticity approach: anchor an inhibitor core in a conserved binding pocket, then extend rigid bulky substituents toward remote specificity pockets, which become accessible upon conformational changes of flexible residues. This approach exemplifies general principles for the design of selective enzyme inhibitors that overcome strong active site conservation.
 
- 
-
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,Garcin ED, Arvai AS, Rosenfeld RJ, Kroeger MD, Crane BR, Andersson G, Andrews G, Hamley PJ, Mallinder PR, Nicholls DJ, St-Gallay SA, Tinker AC, Gensmantel NP, Mete A, Cheshire DR, Connolly S, Stuehr DJ, Aberg A, Wallace AV, Tainer JA, Getzoff ED Nat Chem Biol. 2008 Nov;4(11):700-7. Epub 2008 Oct 12. PMID:18849972<ref>PMID:18849972</ref>
 
- 
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 
-
</div>
 
-
<div class="pdbe-citations 3ej8" style="background-color:#fffaf0;"></div>
 
==See Also==
==See Also==
*[[Nitric Oxide Synthase 3D structures|Nitric Oxide Synthase 3D structures]]
*[[Nitric Oxide Synthase 3D structures|Nitric Oxide Synthase 3D structures]]
-
== References ==
 
-
<references/>
 
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Aberg, A]]
+
[[Category: Aberg A]]
-
[[Category: Andersson, G]]
+
[[Category: Andersson G]]
-
[[Category: Andrews, G]]
+
[[Category: Andrews G]]
-
[[Category: Arvai, A S]]
+
[[Category: Arvai AS]]
-
[[Category: Cheshire, D R]]
+
[[Category: Cheshire DR]]
-
[[Category: Connolly, S]]
+
[[Category: Connolly S]]
-
[[Category: Crane, B R]]
+
[[Category: Crane BR]]
-
[[Category: Garcin, E D]]
+
[[Category: Garcin ED]]
-
[[Category: Gensmantel, N P]]
+
[[Category: Gensmantel NP]]
-
[[Category: Getzoff, E D]]
+
[[Category: Getzoff ED]]
-
[[Category: Hamley, P J]]
+
[[Category: Hamley PJ]]
-
[[Category: Kroeger, M D]]
+
[[Category: Kroeger MD]]
-
[[Category: Mallinder, P R]]
+
[[Category: Mallinder PR]]
-
[[Category: Mete, A]]
+
[[Category: Mete A]]
-
[[Category: Nicholls, D J]]
+
[[Category: Nicholls DJ]]
-
[[Category: Rosenfeld, R J]]
+
[[Category: Rosenfeld RJ]]
-
[[Category: St-Gallay, S A]]
+
[[Category: St-Gallay SA]]
-
[[Category: Stuehr, D J]]
+
[[Category: Stuehr DJ]]
-
[[Category: Tainer, J A]]
+
[[Category: Tainer JA]]
-
[[Category: Tinker, A C]]
+
[[Category: Tinker AC]]
-
[[Category: Wallace, A V]]
+
[[Category: Wallace AV]]
-
[[Category: Fad]]
+
-
[[Category: Fmn]]
+
-
[[Category: Heme]]
+
-
[[Category: Iron]]
+
-
[[Category: Metal-binding]]
+
-
[[Category: Nadp]]
+
-
[[Category: Nitric oxide synthase]]
+
-
[[Category: No]]
+
-
[[Category: Oxidoreductase]]
+
-
[[Category: Oxidoreductase calmodulin-binding]]
+
-
[[Category: Polymorphism]]
+
-
[[Category: Tetrahydrobiopterin]]
+
-
[[Category: Zinc]]
+

Current revision

Structure of double mutant of human iNOS oxygenase domain with bound immidazole

PDB ID 3ej8

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools